GRST - There might be an Eventual Positive Turnaround Going Forward......
***From Mr. Shawn Leon *** <<We are in the middle of an extremely exciting development in West Palm Beach and well-positioned to continue our efforts to eliminate debt while building shareholder value.
***Ethema Health Corporation, together with its subsidiaries, operates substance abuse treatment center.
***Trading at 85.9% below our estimate of its fair value
***Price-To-Earnings vs Peers: GRST is good value based on its Price-To-Earning
***Price to Earnings Ratio vs Industry How does GRST's PE Ratio compare vs other companies in the US Healthcare Industry?
***Price-To-Earnings vs Industry: GRST is good value based on its Price-To-Earnings Ratio (0.6x) compared to the US Healthcare industry average (22.2x)
***Price to Earnings Ratio vs Fair Ratio What is GRST's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
***85.9% Undervalued
***Current Price US$0.0003
***Fair Value US$0.0021
***20% Undervalued About Right
***Significantly Below Fair Value: GRST is trading below fair value by more than 20%.
***Analyst Price Targets What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
***Analyst Forecast: Insufficient data to show price forecast.
***Price-To-Earnings vs Industry: GRST is good value based on its Price-To-Earnings Ratio (0.6x) compared to the US Healthcare industry average (22.2x)
Pass Are they forecast to achieve profitability?
The company is currently profitable Section 3.1
Pass Are revenue and earnings forecast to grow?
Earnings have grown by 32.2% per year over past 5 years Section 3.1 Pass Is their dividend sustainable?
They do not pay a dividend Section 5.0 Pass Do they have high quality earnings?
The company’s earnings are high quality Section 3.1 Pass Do they have sufficient financial data available?
At least 3 years of financial data is available Section 3.0 Pass Are there any concerning recent events?
No concerning events detected Share Price No data Has there been substantial insider selling in the past 3 months?
No 3 month insider trading information ================================================================ Name Position Tenure
Experienced Board: GRST's board of directors are considered experienced (7.3 years average tenure).
Market Data 
Markets 
AI
